Could a heart drug melt fatty liver? new trial begins
NCT ID NCT07238985
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether cilostazol, a drug used for leg pain, can help people with nonalcoholic fatty liver disease (NAFLD). About 50 adults with fatty liver will take the drug to see if it reduces liver fat and lowers fibrosis risk scores. The study aims to find a new treatment option for this common liver condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mostafa Bahaa
RECRUITINGDamietta, New Damietta, 34518, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common b vitamin tame fatty liver?
- HIV and fatty liver: a hidden link under the microscope
- Double liver trouble: does having both hepatitis b and fatty liver speed up disease?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- Liver's Post-Meal secrets could unlock new fatty liver treatments
- Could a probiotic supplement help reverse fatty liver?